Currenc Group에 대한 매도 수량은 투자자에게 Currenc Group의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Currenc Group (NASDAQ:CURR) 주식, 공매도 수량 보고

Currenc Group

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.

Currenc Group Inc

CURRYS PLC U/ADR by CURRYS PLC

CURRENCY EXCHANGE INTL CP by Currency Exchange International Corp

Currency Exchange International Corp

Current Energy and Renewables Corp

CURRENT WATER TECHS INC by Current Water Technologies Inc.

Current Water Technologies Inc

Currys PLC

Investor Kevin O'Leary has an explicit message for CEOs and entrepreneurs wondering if artificial intelligence is a threat to their jobs: It isn't, as long as they learn how to use it. In fact, he believes it could be the biggest opportunity of their careers.
<h2 class="wp-block-heading">&#8216;It&#8217;ll Make Everybody Richer&#8217;</h2>
&#8220;I think it&#8217;ll make everybody richer—if they learn how to use the tool,&#8221; O'Leary said in a recent Forbes Middle East <a href="https://www.youtube.com/watch?v=Gz6nufY2b6c">interview</a>. The longtime investor and &#8220;Shark Tank&#8221; star says AI isn't about replacing CEOs. It's about making them more effective, more productive, and potentially 10 times wealthier.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Is AI going to replace CEOs or just make the existing ones 10 times richer? I think it&#39;ll make everybody richer, if they learn how to use the tool. It&#39;s a re-education to understand how to use the models. We use them in our businesses for example, there&#39;s 95 words in a 15-second… <a href="https://t.co/Xc0WCL6MYM">pic.twitter.com/Xc0WCL6MYM</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1935813912001466867?ref_src=twsrc%5Etfw">June 19, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
</ul>
He backed that up with action. Last month, he announced his team's <a href="https://www.benzinga.com/25/05/45663361/kevin-oleary-wants-to-teach-every-ceo-how-to-use-aiand-hes-hiring-people-to-do-it-calling-it-a-lifetime-career-opportunity">next big hire</a> would be someone dedicated to training CEOs in his portfolio companies on how to use AI tools. &#8220;Training people how to understand and use AI is going to be a lifetime career for many,&#8221; he said in a <a href="https://x.com/kevinolearytv/status/1927895415677972934">video</a> posted to social media.
On the other hand, a 2023 <a href="https://press.edx.org/edx-survey-finds-nearly-half-49-of-ceos-believe-most-or-all-of-their-role-should-be-automated-or-replaced-by-ai">survey</a> by edX found that nearly half of <a href="https://www.benzinga.com/startups/24/11/41776393/49-of-ceos-say-their-role-should-be-automated-but-nvidia-ceo-jensen-huang-responds-absolutely-not-fo">CEOs believe</a> large portions of their work could be taken over by artificial intelligence. In fact, 49% said they're open to having AI handle significant responsibilities normally reserved for top executives.
According to O'Leary, AI is already being used across functions like sales, marketing, social media, and customer support. His team is developing a product called Wonder Engine, which packages the best AI tools from the cloud into a single system for small and midsize businesses.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
<h2 class="wp-block-heading">From Wine To Watches To Real Estate</h2>
O'Leary gave examples from his own companies. In his wine business, he uses AI to predict which varietals will be most popular in each state, so he can stock the right inventory and reduce waste. He also built WonderCare, an AI-powered global insurance platform for high-end watch collectors.&nbsp;
And in the United Arab Emirates, he partnered with a real estate developer who created an AI-integrated smart home system that actually learns from how people live.
<h2 class="wp-block-heading">Why He's Betting On Data Centers</h2>
To O'Leary, the real AI race centers on infrastructure more than software. &#8220;They won't get there without data centers,&#8221; he said, pointing out that demand for AI power in the U.S. is outpacing supply. He's now <a href="https://www.benzinga.com/real-estate/24/12/42486613/kevin-oleary-has-recently-noted-the-increasing-demand-for-data-centers-describing-them-as-a-notable-combination-of-real-estate-and-technology-with-considerable-potential">investing in massive data center projects</a> across North America, powered by cheap, stranded gas and located near key energy infrastructure.
He also praised the UAE as a rising global AI hub. &#8220;Most people think the U.S. leads, China is second. Well, who&#8217;s third? This place,&#8221; he said.
See Also: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a>
<h2 class="wp-block-heading">Execution Over Emotion</h2>
O'Leary has built a reputation for being frank, especially when it comes to business performance. He says the biggest mistake people make with money is getting too emotional. He favors execution, data, and results over charisma or hype. And that applies to AI, too.
&#8220;There&#8217;s two generations: people that know how to use it and those that don&#8217;t,&#8221; O&#8217;Leary said, emphasizing the importance of re-education and daily use of AI tools to stay competitive.
Read Next: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Image: Shutterstock

News

Is AI Going To Replace CEOs Or Just Make Them 10 Times Richer? Kevin O'Leary Says 'It'll Make Everyone Richer'—If They Learn How To Use It

Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) has outperformed the market over the past 10 years by 6.72% on an annualized basis producing an average annual return of 18.01%. Currently, Lennox Intl has a market capitalization of $20.02 billion. 
Buying $1000 In LII: If an investor had bought $1000 of LII stock 10 years ago, it would be worth $5,262.87 today based on a price of $564.18 for LII at the time of writing.
<h3>Lennox Intl's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750717817_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $1000 Invested In Lennox Intl 10 Years Ago Would Be Worth Today

Vanguard has made a sweeping cut in fees across its European fixed income UCITS ETF range that takes effect on July 1, 2025. The change will affect 26 share classes of <a href="https://www.benzinga.com/etfs">seven ETFs</a> and is likely to save investors some $3.5 million per year.
Consistent with its long-standing tradition of low-cost investing, Vanguard fee cuts will be applied across a wide range of fixed income strategies — global bonds, U.S. Treasuries, UK gilts, emerging market sovereign debt and euro- and U.S. dollar-denominated corporate bonds. Hedged and unhedged share classes both fall under the cost-cutting program.
Also Read:<a href="https://www.benzinga.com/etfs/sector-etfs/25/06/46056666/how-a-strait-of-hormuz-shock-could-ignite-a-surge-in-energy-and-defense-etfs"> How A Strait Of Hormuz Shock Could Ignite A Surge In Energy And Defense ETFs</a>
The updated ongoing charges figure (OCF) will position a number of Vanguard&#8217;s ETFs as among the lowest-cost across Europe for core fixed income exposures. For instance, the Vanguard Global Aggregate Bond UCITS ETF (hedged share class) will have its OCF reduced from 0.10% to 0.08%, the Vanguard USD Treasury Bond UCITS ETF&#8216;s unhedged share class will be reduced from 0.07% to 0.05%, and the hedged share class will be lowered from 0.12% to 0.10%. 
In the same manner, the Vanguard U.K. Gilt UCITS ETF and the Vanguard USD Emerging Markets Government Bond UCITS ETF (unhedged) will also see cut OCFs. Corporate bond exposures like the Vanguard EUR Corporate Bond UCITS ETF, the Vanguard ESG EUR Corporate Bond UCITS ETF and the Vanguard USD Corporate Bond UCITS ETF will also have fee reductions
Vanguard reiterated that its purpose is to serve all investors through the delivery of fair value and the highest chance of investment success. With these recent reductions, the company further reinforces its status as Europe&#8217;s lowest-cost provider of average fixed-income ETF range.
&#8220;In investing, you get what you don&#8217;t pay for,&#8221; the company said, pointing out that cheaper fees traditionally equate to improved net returns for investors.
As global central banks continue to rebalance interest rate policies and markets continue to react to macroeconomic changes, Vanguard&#8217;s fee cuts are likely to entice both institutional and individual investors looking for cost-effective fixed income investments.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/06/46060008/why-active-fixed-income-etfs-quietly-dominate-in-2025">Why Active Fixed-Income ETFs Quietly Dominate In 2025</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

Eurozone

Global

ETFs

Vanguard Slashes Fees Across European Fixed Income UCITS ETFs, Enhancing Low-Cost Investing Options

Antero Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>) has outperformed the market over the past 5 years by 63.56% on an annualized basis producing an average annual return of 78.43%. Currently, Antero Resources has a market capitalization of $13.09 billion. 
Buying $100 In AR: If an investor had bought $100 of AR stock 5 years ago, it would be worth $1,615.27 today based on a price of $42.10 for AR at the time of writing.
<h3>Antero Resources's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750716924_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Antero Resources Stock In The Last 5 Years

<a href="https://truthsocial.com/@realDonaldTrump/posts/114734934153569653">https://truthsocial.com/@realDonaldTrump/posts/114734934153569653</a>

Macro Notification

Politics

Economics

General

iShares MSCI Israel Capped Investable Market Index Fund

President Trump Says It Has Been Fully Agreed By And Between Israel And Iran That There Will Be A Complete And Total Ceasefire; For 12 Hours, At Which Point War Will Be Considered, Ended; : Officially, Iran Will Start Ceasefire And, Upon 12th Hour, Israel Will Start Ceasefire;  Upon 24th Hour, An Official End To 12 Day War; During Each Ceasefire, Other Side Will Remain Peaceful And Respectful

In the current session, the stock is trading at $116.97, after a 1.36% increase. Over the past month, Duke Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DUK#NYSE">DUK</a>) stock increased by 0.51%, and in the past year, by 16.74%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1750716075_0.png" alt="Past Year Chart" />

<h3>Duke Energy P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 19.21 in the Electric Utilities industry, Duke Energy Inc. has a lower P/E ratio of 19.15. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1750716075_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

A Look Into Duke Energy Inc's Price Over Earnings

Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $55.0, a high estimate of $68.00, and a low estimate of $42.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 3.22%. 
<img src="https://www.benzinga.com/files/images/story/2025/1750716054_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A clear picture of Moelis's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$68.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>James Yaro</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$63.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$52.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$50.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$55.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$42.00</td>
<td>$70.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Moelis. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Moelis compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Moelis's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Moelis's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/MC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Moelis analyst ratings.</a>
<h2>All You Need to Know About Moelis</h2>
Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.
<h3>Moelis: A Financial Overview</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Moelis's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 40.97%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 16.4%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Moelis's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 10.86%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.89%, the company showcases effective utilization of assets.
Debt Management: Moelis's debt-to-equity ratio is below the industry average at 0.45, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

6 Analysts Assess Moelis: What You Need To Know

American Tower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>) has outperformed the market over the past 20 years by 4.08% on an annualized basis producing an average annual return of 12.5%. Currently, American Tower has a market capitalization of $103.75 billion. 
Buying $100 In AMT: If an investor had bought $100 of AMT stock 20 years ago, it would be worth $1,065.53 today based on a price of $221.63 for AMT at the time of writing.
<h3>American Tower's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750715112_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In American Tower 20 Years Ago Would Be Worth Today

Shares of AI cloud infrastructure provider CoreWeave Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) fell 5.39% to $173.68 on Monday, reversing some of last week's sharp gains. The decline comes amid broad market volatility, driven by escalating tensions in the Middle East that are beginning to rattle global trade and energy flows.
What To Know: The sell-off in CoreWeave likely reflects profit-taking after <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45984765/coreweave-crwv-stock-hits-new-all-time-high-today-whats-going-on">last week&#8217;s rally</a> to a record high of $187. Despite no major company news, CoreWeave surged on continued AI enthusiasm and a strong fundamental backdrop, including a 420% revenue jump and a $25.9 billion backlog.
Still, a recent analyst <a href="https://www.benzinga.com/quote/CRWV/analyst-ratings">downgrade</a> from Bank of America citing valuation concerns, added pressure.
Read Also: <a href="https://www.benzinga.com/news/25/06/46055156/sp500-oil-crisis-performance-iran">War, Oil, And S&amp;P 500: Here&#8217;s How The Stock Market Behaves In Energy Crises</a>
Market Update: The market has been extremely volatile on Monday as maritime traffic data from key chokepoints such as the Strait of Hormuz and the Suez Canal shows <a href="https://www.benzinga.com/news/politics/25/06/46047021/iran-threatens-strait-of-hormuz-after-us-bombs-its-nuclear-sites-shipping-traffic-plunges">steep declines</a> across crude oil tankers, container ships and bulk carriers, suggesting rising geopolitical risk and potential supply chain disruptions.
Notably, container traffic has plunged over 21% through Hormuz and nearly 31% through Suez, pointing to both rerouting and weakened demand, especially from industrial powerhouses like China.
With Iran&#8217;s parliament voting to potentially close the Strait of Hormuz, markets are bracing for further volatility, leaving high-growth names like CoreWeave potentially exposed. According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, CRWV has a 52-week high of $187 and a 52-week low of $33.52.
Read Also: <a href="https://www.benzinga.com/news/25/06/46055156/sp500-oil-crisis-performance-iran">War, Oil, And S&amp;P 500: Here&#8217;s How The Stock Market Behaves In Energy Crises</a>
<h1 class="wp-block-heading">How To Buy CRWV Stock</h1>
By now, you're likely curious about how to participate in the market for CoreWeave, be it to purchase shares or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading — either way, it allows you to profit from the share price decline.
Image: Shutterstock

Tech

CRWV

CoreWeave (CRWV) Stock Falls Sharply Monday: What Happened?

TLSI

TriSalus Life Sciences Initiates Exchange Offer And Consent Solicitation Relating To Series A Convertible Preferred Stock To Streamline Capital Structure

Buybacks

BLFY

Blue Foundry Bancorp Authorizes The Adoption Of Its Sixth Stock Repurchase Program To Repurchase Up To 1,082,533 Shares Of The Company's Common Stock, Which Is ~5% Of Its Outstanding Common Stock

Essential Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPRT#NYSE">EPRT</a>) has outperformed the market over the past 5 years by 1.56% on an annualized basis producing an average annual return of 16.43%. Currently, Essential Properties has a market capitalization of $6.49 billion. 
Buying $100 In EPRT: If an investor had bought $100 of EPRT stock 5 years ago, it would be worth $206.45 today based on a price of $32.86 for EPRT at the time of writing.
<h3>Essential Properties's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750714223_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EPRT

Here's How Much You Would Have Made Owning Essential Properties Stock In The Last 5 Years

<a href="https://www.bloomberg.com/news/articles/2025-06-23/tesla-robotaxi-videos-show-speeding-driving-into-wrong-lane?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-23/tesla-robotaxi-videos-show-speeding-driving-into-wrong-lane?embedded-checkout=true</a>

TSLA

'Tesla Robotaxi Issues Draw Scrutiny From Auto Safety Regulator'- Bloomberg

Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) has outperformed the market over the past 20 years by 3.59% on an annualized basis producing an average annual return of 12.01%. Currently, Gilead Sciences has a market capitalization of $132.09 billion. 
Buying $1000 In GILD: If an investor had bought $1000 of GILD stock 20 years ago, it would be worth $9,798.39 today based on a price of $106.19 for GILD at the time of writing.
<h3>Gilead Sciences's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750713324_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GILD

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today

<a href="https://www.bloomberg.com/news/articles/2025-06-23/starbucks-rises-on-report-it-s-mulling-sale-of-china-business">https://www.bloomberg.com/news/articles/2025-06-23/starbucks-rises-on-report-it-s-mulling-sale-of-china-business</a>

SBUX

'Starbucks Rises on Report It's Mulling Sale of China Business'- Bloomberg

DATROWAY Approved In The U.S. As First TROP2 Directed Therapy For Patients With Previously Treated Advanced EGFR-mutated Non-Small Cell Lung Cancer; DATROWAY Is Being Jointly Developed And Commercialized By Daiichi Sankyo And AstraZeneca

WIIM

CHWY

CHWY stock has given up its prior loss. Chewy shares were trading lower after the company announced a public offering of Class A common stock by a selling stockholder and a concurrent share repurchase.

Contracts

Oceaneering International Awarded U.S. Navy Contract; The Contract Value Is ~ $33M If All Options Are Exercised Over The Five-Year Ordering Period

<h3>Gainers</h3>
<ul>
<li>GIBO Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIBO#NASDAQ">GIBO</a>) shares moved upwards by 17.8% to $0.67 during Monday's after-market session. The company's market cap stands at $681.8 million. </li>
<li>TEN Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHLD#NASDAQ">XHLD</a>) stock rose 6.96% to $0.47. The company's market cap stands at $12.5 million. </li>
<li>Baosheng Media Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) shares moved upwards by 6.13% to $2.77. The company's market cap stands at $4.1 million. </li>
<li>Taboola.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBLA#NASDAQ">TBLA</a>) stock rose 4.4% to $3.79. The company's market cap stands at $1.1 billion. </li>
<li>DHI Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHX#NYSE">DHX</a>) shares rose 4.08% to $2.8. The company's market cap stands at $124.8 million. </li>
<li>Ziff Davis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZD#NASDAQ">ZD</a>) shares increased by 4.04% to $32.89. The market value of their outstanding shares is at $1.3 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>E W Scripps (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSP#NASDAQ">SSP</a>) shares declined by 7.2% to $2.85 during Monday's after-market session. The company's market cap stands at $273.1 million. </li>
<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) stock decreased by 6.43% to $0.16. The company's market cap stands at $2.2 million. </li>
<li>Brag House Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBH#NASDAQ">TBH</a>) stock declined by 5.62% to $0.77. The market value of their outstanding shares is at $8.6 million. </li>
<li>Grupo Televisa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TV#NYSE">TV</a>) stock declined by 4.65% to $2.26. The company's market cap stands at $2.4 billion. </li>
<li>Beasley Broadcast Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBGI#NASDAQ">BBGI</a>) stock decreased by 3.68% to $4.19. The market value of their outstanding shares is at $8.3 million. </li>
<li>Moving iMage Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#AMEX">MITQ</a>) shares decreased by 3.61% to $0.67. The company's market cap stands at $8.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BAOS

BBGI

BLMZ

GIBO

MITQ

TBLA

XHLD

12 Communication Services Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>TuHURA Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HURA#NASDAQ">HURA</a>) stock moved upwards by 53.8% to $3.86 during Monday's after-market session. The company's market cap stands at $111.3 million. </li>
<li>iBio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIO#NASDAQ">IBIO</a>) stock increased by 42.3% to $1.02. The market value of their outstanding shares is at $12.5 million. </li>
<li>Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>) shares moved upwards by 22.11% to $11.65. The market value of their outstanding shares is at $105.5 million. </li>
<li>Xenetic Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XBIO#NASDAQ">XBIO</a>) stock moved upwards by 14.96% to $3.15. The company's market cap stands at $4.2 million. </li>
<li>Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) stock rose 9.82% to $0.28. The market value of their outstanding shares is at $15.8 million. </li>
<li>CERo Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) shares increased by 9.22% to $9.0. The market value of their outstanding shares is at $5.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) stock fell 19.3% to $1.3 during Monday's after-market session. The market value of their outstanding shares is at $4.3 million. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) stock decreased by 6.88% to $0.28. The company's market cap stands at $1.1 million. </li>
<li>Apyx Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APYX#NASDAQ">APYX</a>) stock declined by 6.87% to $1.9. The market value of their outstanding shares is at $75.5 million. </li>
<li>CARISMA Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARM#NASDAQ">CARM</a>) shares declined by 5.87% to $0.43. The market value of their outstanding shares is at $18.4 million. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) shares decreased by 5.36% to $0.22. The company's market cap stands at $12.6 million. </li>
<li>Femasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) stock declined by 5.29% to $0.86. The company's market cap stands at $27.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Currenc Group

매도 수량

Currenc Group (NASDAQ:CURR) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌